Skip to main content

Table 2 Results of platelet aggregometry assays

From: Better detection of platelet aggregation in patients with metabolic syndrome using epinephrine and ADP

  Healthy individuals Patients with MS% P
  (n = 53) (n = 56)  
ADP 2.34 μM 61.4 ± 11.7 59.2 ± 8.9 0.2739
ADP 1.17 μM 53.8 ± 12.3 32.4 ± 19.9 0.0001*
ADP 0.58 μM 38.5 ± 8.85 43.5 ± 7.2 0.0017*
Epinephrine 11.0 μM 47.4 ± 15.0 84.0 ± 30.8 <0.0001*
Epinephrine 1.1 μM 36.4 ± 15.2 14.8 ± 17.3 <0.0001*
Epinephrine 0.55 μM 17.4 ± 4.7 26.8 ± 7.7 <0.0001*
  1. ADP adenosine diphosphate, MS metabolic syndrome. All values are presented as mean ± SD. Differences between groups were estimated using a Unpaired t test with Welch's correction. *statistically significant.